An article from the KPMG SPAC Intel Hub.
Many private companies thinking of going public want to know if merging with a SPAC would be preferable to an IPO. The short answer: It depends. While a private company may find certain advantages in a SPAC merger—such as speed and a guaranteed price—it has its own challenges. One of the greatest of these is finding the best-fit SPAC sponsor in a sea of possibilities.
In an IPO, a private company issues new shares and, with the help of an underwriter, sells them on a public exchange.1 In a SPAC transaction, the private company becomes publicly traded by merging with a listed shell company—the special-purpose acquisition company (SPAC).
The main advantages of going public with a SPAC merger over an IPO are:
Faster execution than an IPO: A SPAC merger usually occurs in 3–6 months on average, while an IPO usually takes 12–18 months.
The main risks of going public with a SPAC merger over an IPO are:
For private companies interested in pursuing a SPAC merger, analysis of recently completed transactions may be helpful in gauging the prospects for their own deals in the future. Between 2018 and 2020 when the current SPAC boom took off, the largest deals in terms of size and volume were in industrial manufacturing, likely due to the attractiveness of futuristic sectors such as electric vehicles and space tourism.
By revenue, most target companies fell under the $500 million range regardless of the industry. The three biggest targets, all with revenue of more than $3 billion, were in 1) industrial manufacturing, 2) technology, media and telecom, and 3) consumer, retail and travel. But the relatively modest revenue sizes indicate that many SPAC targets are valued for their future financial potential.
A look at net income makes it even clearer that SPAC targets tend to be developing companies. Across all industries, a vast majority of the companies merging with SPACs in the last two years were not yet profitable. Most of them showed losses of $100 million or less, but a couple of the targets—in consumer, retail and travel, and healthcare and life sciences—were more than $300 million in the red. Meanwhile, the two most profitable targets were $173 million (energy and sustainability) and $132 million (financial services) in the black.
Download the document and see exhibits 2 and 3 for more details on 2018-2020 deal sizes, target company revenues and target company net incomes.
The recent flurry of SPAC launches means the demand for target companies is also soaring. As of the start of 2021, more than 200 SPACs were looking for targets. Most of them must seal a merger within the next two years, given the typical lifecycle of 18-24 months for SPACs after which they must liquidate.
In addition to these timelines, two other factors drive a SPAC’s search for targets: the SPAC’s capital and industry preference. About half of SPACs have $200 million to $400 million at their disposal and slightly more than a quarter have less than $200 million to spend. But the ability of SPACs to raise additional capital through debt and PIPE funding means they can pursue deals that are two or three times those amounts.
Not all SPACs target specific industries, but almost 80 percent do. Many are focused on technology, media and telecom (28.6 percent), and healthcare and life sciences (19.2 percent).
Going public by merging with a SPAC rather than by launching an IPO is worth considering for an increasing number of private companies. All the SPACs courting targets at this time may make M&A seem even more enticing. But there are pros and cons to each option. One way to decide which is the better one is to survey the current SPAC landscape and see if your company would really be comfortable exploring there. If you do, the next step is to find the right SPAC suitor that matches your specific criteria (which is the topic of an upcoming paper, “Diligencing SPACs”).